1.MiR-663a Inhibits Radiation-Induced Epithelium-to-Mesenchymal Transition by Targeting TGF-β1.
Pei QU ; Zhi Ang SHAO ; Bing WANG ; Jin Peng HE ; Ya Nan ZHANG ; Wen Jun WEI ; Jun Rui HUA ; Heng ZHOU ; Dong LU ; Nan DING ; Ju Fang WANG
Biomedical and Environmental Sciences 2022;35(5):437-447
Objective:
miR-663a has been reported to be downregulated by X-ray irradiation and participates in radiation-induced bystander effect via TGF-β1. The goal of this study was to explore the role of miR-663a during radiation-induced Epithelium-to-mesenchymal transition (EMT).
Methods:
TGF-β1 or IR was used to induce EMT. After miR-663a transfection, cell migration and cell morphological changes were detected and the expression levels of miR-663a, TGF-β1, and EMT-related factors were quantified.
Results:
Enhancement of cell migration and promotion of mesenchymal changes induced by either TGF-β1 or radiation were suppressed by miR-663a. Furthermore, both X-ray and carbon ion irradiation resulted in the upregulation of TGF-β1 and downregulation of miR-663a, while the silencing of TGF-β1 by miR-663a reversed the EMT process after radiation.
Conclusion
Our findings demonstrate an EMT-suppressing effect by miR-663a via TGF-β1 in radiation-induced EMT.
Down-Regulation
;
Epithelial-Mesenchymal Transition
;
Epithelium/metabolism*
;
MicroRNAs/metabolism*
;
Transforming Growth Factor beta1/pharmacology*
2.Topoisomerase Ⅱα Gene as a Marker for Prognostic Prediction of Hepatocellular Carcinoma: A Bioinformatics Analysis.
Lu JIN ; An SHAO-GUANG ; Ma JUN-JIE ; Yang YUE ; Zhang LEI ; Yu PENG ; Tao HENG ; Chen YUN-FAN ; Zhang HAO-XUAN
Chinese Medical Sciences Journal 2022;37(4):331-339
Objective To investigate the expression of topoisomeraseⅡα (TOP2α) in hepatocellular carcinoma (HCC) and its role in predicting prognosis of HCC patients. Methods We used HCC-related datasets in UALCAN, HCCDB, and cBioPortal databases to analyze the expression and mutation of TOP2α and its co-expressed genes in HCC tissues. GO function and KEGG pathway enrichment of TOP2α and its co-expressed genes were identified. The TIMER database was used to analyze infiltration levels of immune cells in HCC. The impacts of TOP2α and its co-expression genes and the infiltrated immune cells on the survival of HCC patients were assayed by Kaplan-Meier plotter analysis. Results TOP2α and its co-expression genes were highly expressed in HCC (P< 0.001) and detrimental to overall survival of HCC patients (P< 0.001). TOP2α and its co-expression genes were mainly involved in cell mitosis and proliferation, and cell cycle pathway (ID: hsa04110, P = 0.001945). TOP2α and its co-expression genes were mutated in HCC and the mutations were significantly detrimental to overall survival (P = 0.0247) and disease-free survival (P = 0.0265) of HCC patients. High TOP2α expression was positively correlated with the infiltration of B cell (r = 0.459, P< 0.01), CD8+ T cell (r = 0.312, P< 0.01), CD4+ T cell (r = 0.370, P< 0.01), macrophage (r = 0.459, P< 0.01), neutrophil (r = 0.405, P< 0.01), and dendritic cell (r = 0.473, P< 0.01) in HCC. The CD8+ T cell infiltration significantly prolonged the 3- and 5-year survival of HCC patients (all P< 0.05), and CD4+ T cell infiltration significantly shortened the 3-, 5-, and 10-year survival of HCC patients (all P< 0.05). ConclusionTOP2α may be an oncogene, which was associated with poor prognosis of HCC patients and could be used as a biomarker for the prognostic prediction of HCC.
Humans
;
Biomarkers, Tumor/genetics*
;
Carcinoma, Hepatocellular/genetics*
;
CD8-Positive T-Lymphocytes
;
Computational Biology
;
Liver Neoplasms/genetics*
;
Prognosis
;
DNA Topoisomerases, Type II/genetics*
3.Correlative study of bufogenin constituents in venom of Bufo bufo gargarizans.
Yue-Ting CAO ; Ke-Ke CUI ; Ji-Heng WU ; Hong-Ye PAN ; Zheng-Yu LU ; Jia-Feng SHAO ; Long-Hu WANG
China Journal of Chinese Materia Medica 2019;44(9):1850-1856
As known,simultaneous determination of various chemical indicators is one of the future trends in quality control of traditional Chinese medicines because of the extremely complex chemical compositions. This project is to screen the quality markers that can accurately control the quality of the Bufonis Venenum by exploring the intrinsic correlation of components. In this study,venom of Bufo bufo gargarizans from 17 different sources were used as research samples,and the contents of 7 bufogenin were determined by HPLC-DAD. Then,the data obtained were analyzed by Spearman correlation analysis and principal component analysis( PCA). In addition,a stepwise regression analysis was used to establish a predictive model for the contents of the seven bufogenin components( independent variable) and the total contents of the bufogenin( dependent variable). The results indicated that there is a significant positive correlation between the contents of telocinobufagin and cinobufotalin,and there is a significant positive correlation between the contents of bufalin,cinobufagin and resibufogenin. In contrast,the contents of telocinobufagin and cinobufotalin are negatively correlated with the contents of bufalin,cinobufagin and resibufogenin. However,the correlation between gamabufotalin and bufotalin and other components are not obvious. Furthermore,further study found that there is a correlation between the sum of the contents of bufalin,cinobufagin and telocinobufagin and the total contents of the bufogenin. In fact,the application of bufalin,cinobufagin and telocinobufagin as the quality control indicators of the Bufonis Venenum can better reflect the quality characteristics of the Bufonis Venenum compared with the previous quality control indicators. The conclusions will provide a reference for the revision of the quality standards of the Bufonis Venenum.
Amphibian Venoms
;
chemistry
;
Animals
;
Bufanolides
;
analysis
;
Bufo bufo
;
Chromatography, High Pressure Liquid
;
Medicine, Chinese Traditional
;
Quality Control
4.Rare parotid gland tumors: enhanced computed tomography and pathological correlation.
Xiaoling WEN ; Jiang SHEN ; Dongsheng WU ; Heng SHAO ; Lu LIU ; Chunhua XU
West China Journal of Stomatology 2015;33(4):414-418
OBJECTIVETo investigate the correlation between enhanced computed tomography (CT) findings and pathological results of rare parotid gland tumors, and improve diagnosis accuracy.
METHODSThe enhanced CT manifestations of 22 cases with pathologically documented rare parotid gland tumors, which included 6 cases of basal cell tumor, 5 cases of myoepithelioma, 4 cases of vascular invasion, 3 cases of lymphatic cyst, 3 cases of lipoma, and 1 case of chondrosarcoma, were retrospectively analyzed. The location, size, shape, density, and relationship with surrounding structure were evaluated on CT images.
RESULTSThe enhanced CT showed that basal cell tumors occurred in the superficial lobe of the parotid gland, with clear boundary, within the cystic lesion. The lesions were moderate to obviously enhanced, which may be accompanied by enlarged lymph nodes. Myoepithelial tumors were located in the superficial lobe of the parotid gland, with a small cystic prone and microcalcification within a few cases. The lesions were moderate to obviously enhanced. Hemangiomas of soft tissue mass prominent in the parotid gland surface were mild to significantly enhanced. Larger lesions may occupy the entire parotid gland, with uneven density and visible vein stone. The CT density values of the lymphatic cyst were usually higher. Chondrosarcoma mainly manifested cystic mass at the calcification edge. Lipoma with fat density mass exhibited clear boundary without enhancement. Fiber separation could be observed in the lesion.
CONCLUSIONCT can reflect the pathological features of rare parotid gland tumors by demonstrating their corresponding imaging features. Enhanced CT is the most effective means of imaging to identify the nature of rare tumor of the parotid gland lesions.
Chondrosarcoma ; Hemangioma ; Humans ; Lipoma ; Parotid Gland ; Parotid Neoplasms ; Retrospective Studies ; Tomography, X-Ray Computed
5.Parotid adenolymphoma: the enhanced MSCT manifestations and clinical pathological analysis.
Jiang SHEN ; Heng SHAO ; Dongsheng WU ; Lu LIU ; Chunhua XU ; Xiaoling WEN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(24):2129-2132
OBJECTIVE:
To investigate the imaging manifestations of 16-slice enhanced CT of parotid adenolymphoma in the parotid gland and the corresponding pathology,in order to improve the understanding of the CT imaging manifestations of parotid adenolymphoma in the parotid gland.
METHOD:
The enhanced CT characteristics of 34 cases of parotid adenolymphoma in the parotid gland confirmed by histological pathology were retrospectively analyzed.
RESULT:
There were totally 86 lesions in 34 cases, of which 12 cases with lesions in bilateral sides and 22 cases with lesions in unilateral side. Sixty-six lesions located behind and below the superficial lobe of the parotid gland. The lesions showed moderate to obvious enhancement at arterial phase, and the cystic region within the lesions showed no enhancement.
CONCLUSION
The relatively specific enhanced MSCT manifestations of parotid adenolymphoma in parotid gland include lesions located behind and below the superficial lobe of parotid gland unilaterally or bilaterally, sometimes exhibited as multiple masses, with clear edge, obvious enhancement and cystic degeneration inside.
Adenolymphoma
;
diagnosis
;
pathology
;
Humans
;
Parotid Gland
;
pathology
;
Parotid Neoplasms
;
diagnosis
;
pathology
;
Tomography, X-Ray Computed
6.Rare parotid gland tumors:enhanced computed tomography and pathological correlation
Xiaoling WEN ; Jiang SHEN ; Dongsheng WU ; Heng SHAO ; Lu LIU ; Chunhua XU
West China Journal of Stomatology 2015;(4):414-418
Objective??To?investigate?the?correlation?between?enhanced?computed?tomography?(CT)?findings?and?patholo-gical?results?of?rare?parotid?gland?tumors,?and?improve?diagnosis?accuracy. Methods??The?enhanced?CT?manifestations?of?22?cases?with?pathologically?documented?rare?parotid?gland?tumors,?which?included?6?cases?of?basal?cell?tumor,?5?cases?of?myoepithelioma,?4?cases?of?vascular?invasion,?3?cases?of?lymphatic?cyst,?3?cases?of?lipoma,?and?1?case?of?chondrosarcoma,?were?retrospectively?analyzed.?The?location,?size,?shape,?density,?and?relationship?with?surrounding?structure?were?evaluated?on?CT?images.?Results??The?enhanced?CT?showed?that?basal?cell?tumors?occurred?in?the?superficial?lobe?of?the?parotid?gland,?with?clear?boundary,?within?the?cystic?lesion.?The?lesions?were?moderate?to?obviously?enhanced,?which?may?be?accompanied?by?enlarged?lymph?nodes.?Myoepithelial?tumors?were?located?in?the?superficial?lobe?of?the?parotid?gland,?with?a?small?cystic?prone?and?microcalcification?within?a?few?cases.?The?lesions?were?moderate?to?obviously?enhanced.?Hemangiomas?of?soft?tissue?mass?prominent?in?the?parotid?gland?surface?were?mild?to?significantly?enhanced.?Larger?lesions?may?occupy?the?entire?parotid?gland,?with?uneven?density?and?visible?vein?stone.?The?CT?density?values?of??the??lymphatic?cyst?were?usually?higher.?Chondrosarcoma?mainly?manifested?cystic?mass?at?the?calcification?edge.?Lipoma?with?fat?density?mass?exhibited?clear?boun-dary?without?enhancement.?Fiber?separation?could?be?observed?in?the?lesion.?Conclusion??CT?can?reflect?the?pathological?features?of?rare?parotid?gland?tumors?by?demonstrating?their?corresponding?imaging?features.?Enhanced?CT?is?the?most?effec-tive?means?of?imaging?to?identify?the?nature?of?rare?tumor?of?the?parotid?gland?lesions.
7.Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.
Heng-Yi LIANG ; Li-Gong LU ; Bao-Shan HU ; Yong LI ; Pei-Jian SHAO
Chinese Medical Journal 2013;126(22):4270-4276
BACKGROUNDThe prognosis of unresectable large hepatocellular carcinomas is poor. This study evaluated the efficacy and safety of sorafenib combined with transcatheter arterial chemoembolization and radiofrequency ablation in the treatment of hepatocellular carcinomas larger than 5 cm.
METHODSThe treatment of 22 patients with large, unresectable hepatocellular carcinomas (5.0-16.5 cm) treated with sorafenib after transcatheter arterial chemoembolization combined with radiofrequency ablation between 2007 and 2011 was reviewed. The local effects, survival rates, toxicity, and prognostic factors were analyzed.
RESULTSDuring a follow-up of 9-49 months, 19 patients died and three survived. The median overall survival was 32 months. The overall cumulative 12, 24, and 36-month survival rates were 85.9%, 66.8%, and 23.5% respectively. Technical effectiveness was achieved in 12 out of 28 lesions (42.85%) at the first CT check. The median time to tumor progression was 21 months. The progression-free survival rates at 6, 12, and 24 months were 90.9%, 72.0%, and 38.4%, respectively. Combined therapy was generally well tolerated. There was only one major procedure-related complication, biloma (4.5%). Sorafenib-related adverse events exceeding grade 3 were hand-foot skin reaction (2/22, 9.1%), gastrointestinal hemorrhage (1/22, 4.5%), and diarrhea (2/22, 9.1%). The absence of vascular invasion before treatment was found to be the best prognostic factor in the univariate analysis.
CONCLUSIONSSorafenib combined with transcatheter arterial chemoembolization and radiofrequency ablation is a promising approach to the treatment of large, unresectable hepatocellular carcinomas. However, large-scale randomized clinical trials are needed to determine the future role of this treatment.
Adult ; Antineoplastic Agents ; therapeutic use ; Carcinoma, Hepatocellular ; drug therapy ; therapy ; Catheter Ablation ; Chemoembolization, Therapeutic ; methods ; Female ; Humans ; Liver Neoplasms ; drug therapy ; therapy ; Male ; Middle Aged ; Niacinamide ; analogs & derivatives ; therapeutic use ; Phenylurea Compounds ; therapeutic use ; Retrospective Studies ; Treatment Outcome
9.Study on between magnetic resonance venography and digital subtraction angiography on the inferior vena cava obstructive interface morphology of Budd-Chiari syndrome.
Xin LU ; Kai XU ; Qing-qiao ZHANG ; Chun YANG ; Shao-dong LI ; Jiang-shan LI ; Yu-tao RONG ; Mao-heng ZHU
Chinese Journal of Hepatology 2011;19(12):923-926
OBJECTIVETo evaluate magnetic resonance venography (MRV) in diagnosing obstructive interface morphology of Budd-Chiari syndrome(BCS).
METHODSMRV examination was performed on 44 cases of BCS, and the images of obstructive interface morphology of the inferior vena cava were reviewed by two radiologists.
RESULTSIn all 44 cases, there were 37 cases with complete obstruction and 7 with incomplete obstruction. MRV showed 4 cases with membrane with hole of incomplete obstruction. The morphologies MRV demonstrated that the proximal part of the 37 cases with complete obstruction were mainly divided into the cone type (36 cases) and the planum type (1 case). Besides, the type of distal end of obstruction were the cone type (30 cases), the planum type (4 cases) and the irregular type (3 cases). The overall sensitivity, specificity, positive and negative predictive values for the diagnosis of MRV were respectively 100%%, 57.1%, 92.5% and 100% as compared to the DSA.
CONCLUSIONThe examination of MRV is capable of revealing the obstructive interface morphology of the inferior vena cava, especially for the distal end of obstruction. MRV can provide guidelines in interventional treatment of Budd-Chiari syndrome.
Adult ; Aged ; Angiography, Digital Subtraction ; Budd-Chiari Syndrome ; diagnostic imaging ; pathology ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Vena Cava, Inferior ; diagnostic imaging ; pathology ; Young Adult
10.Risk factors for postoperative seromas in Chinese breast cancer patients.
Yan-ping LIN ; Wen-jin YIN ; Ting-ting YAN ; Li-heng ZHOU ; Geng-hong DI ; Jiong WU ; Zhen-zhou SHEN ; Zhi-min SHAO ; Jin-song LU
Chinese Medical Journal 2011;124(9):1300-1304
BACKGROUNDSeroma formation is one of the most common complications after breast cancer surgery. Various risk factors have been evaluated for their associations with the development of seromas in Western populations. However, similar data are not available in Chinese series. Therefore, we sought to investigate the potential risk factors for Chinese breast cancer patients.
METHODSA prospective study of female breast cancer patients undergoing surgery was carried out in Cancer Hospital of Fudan University, Shanghai, China. Univariate analyses were performed by chi-square test or Student's t test or Mann-Whitney test and multivariate analyses by stepwise Logistic regression. The logistic model included age (years), total serum protein concentration (g/L), drainage volume on postoperative day 3 (POD 3; ml) and time to daily drainage volume not more than 30 ml (TTV30; days).
RESULTSA total of 158 patients with breast cancer were studied. The mean age at diagnosis was (52.14 ± 10.77) years (range 25 - 92). During the follow-up period, 24 (15.2%) patients developed seromas. Calculated as continuous variables in the stepwise Logistic regression, age (OR = 1.090, 95%CI 1.028 - 1.155, P = 0.004), total serum protein concentration (OR = 0.886, 95%CI 0.791 - 0.992, P = 0.036), drainage volume on POD3 (OR = 1.013, 95%CI 1.002 - 1.023, P = 0.017) and TTV30 (OR = 1.273, 95%CI 1.039 - 1.561, P = 0.020) were independent risk factors for seroma formation. Additionally, significant difference in daily drainage volume was substantiated in the analysis by seroma formation (P = 0.034) rather than by type of surgery (P = 0.713).
CONCLUSIONSAlthough the pathogenesis of seroma remains controversial, such risk factors as age, nutritional status, drainage volume on POD3 and TTV30 should be considered for prediction and prevention of seroma formation in Chinese breast cancer patients.
Adult ; Aged ; Aged, 80 and over ; Asian Continental Ancestry Group ; Breast Neoplasms ; surgery ; Female ; Humans ; Middle Aged ; Postoperative Complications ; Prospective Studies ; Risk Factors ; Seroma ; etiology

Result Analysis
Print
Save
E-mail